Osteoporosis

Should Trabecular Bone Score Be Used to Predict Fragility Fracture Risk in T1D?

Should Trabecular Bone Score Be Used to Predict Fragility Fracture Risk in T1D?

By

Fragility fracture risk increased with age and decreased with higher BMD in patients with type 1 diabetes.

Leg Positioning During Lumbar DXA Does Not Impact Trabecular Bone Scores

Leg Positioning During Lumbar DXA Does Not Impact Trabecular Bone Scores

By

Researchers evaluated trabecular bone scores in 114 women during either "legs up" or "legs down" dual energy x-ray absorptiometry scans.

Remote Osteoporosis Specialist Mentoring Program Improves Physician Self-Confidence

Remote Osteoporosis Specialist Mentoring Program Improves Physician Self-Confidence

By

The Bone Health TeleECHO Clinic helps mentor healthcare professionals and improves osteoporosis care in underserved communities.

DXA for Pediatric Bone Age Assessment Yields Similar Results vs Traditional Radiography

DXA for Pediatric Bone Age Assessment Yields Similar Results vs Traditional Radiography

By

Dual-energy X-ray absorptiometry for bone age assessment complements traditional radiologic assessment.

The Handoff: Your Week in Rheumatology News - 4/14/17

The Handoff: Your Week in Rheumatology News - 4/14/17

By

This week, a phase III trial for investigational drug voclosporin for lupus nephritis treatment was approved, prolonged insomnia may lead to less robust bone formation — causing osteoporosis and bone fractures — and researchers found that women who drink a moderate amount of alcohol daily have a reduced risk of developing systemic lupus erythmatosus.

Postmenopause Osteoporosis Drug Denosumab Demonstrates Long-term Safety

Postmenopause Osteoporosis Drug Denosumab Demonstrates Long-term Safety

By

Three-year fracture study examines the effects of osteoporosis drug denosumab on fractures, bone mineral density, and bone turnover markers in postmenopausal women with osteoporosis.

Anti-fracture Therapy Prevents Bone Loss in Women After Critical Illness

Anti-fracture Therapy Prevents Bone Loss in Women After Critical Illness

By

Prospective observational cohort study examines association between post-ICU administration of anti-fracture therapy or glucocorticoids and longitudinal changes in bone mineral density.

Bone and Basal Metabolism Linked to Vitamin D Levels

Bone and Basal Metabolism Linked to Vitamin D Levels

By

For postmenopausal women with type 2 diabetes mellitus, the correlation between bone and basal metabolism depends on serum 25-hyroxyvitamin D levels.

Hypophosphatasia Associated With Significant Fracture Burden and Psychological Comorbidities

Hypophosphatasia Associated With Significant Fracture Burden and Psychological Comorbidities

By

Study used the University of Utah Health Care electronic health record (EHR) database, which contained data from 1.6 million patients.

The Handoff: Your Week in Rheumatology News - 4/7/17

The Handoff: Your Week in Rheumatology News - 4/7/17

By

WCO 2017, FDA grants Rituxan Breakthrough Therapy status, and a close-up of pediatric Sjögren's syndrome highlight this week's The Handoff.

Testosterone Treatment Increases Bone Mineral Density and Strength in Older Men

Testosterone Treatment Increases Bone Mineral Density and Strength in Older Men

By

Testosterone treatments help improve volumetric bone mineral density and bone strength in elderly men with low testosterone.

Osteoporosis Care After Hip Fracture Underused by Older Women

Osteoporosis Care After Hip Fracture Underused by Older Women

By

Observational study examines use of osteoporosis-related assessments and treatment in women who experienced their first hip fracture.

Utility of Trabecular Bone Score in Assessing Bone Quality in Type 2 Diabetes

Utility of Trabecular Bone Score in Assessing Bone Quality in Type 2 Diabetes

By

The trabecular bone score may provides an acute, albeit indirect, measurement of bone quality in patients with type 2 diabetes.

Predicting Vertebral Fracture Risk After Bisphosphonate Drug Holiday

Predicting Vertebral Fracture Risk After Bisphosphonate Drug Holiday

By

Study examines the predictive value for vertebral fractures of bone mineral density and bone turnover markers after a 5-year drug holiday.

Postmenopausal Osteoporosis Bisphosphonate Drug Holiday Increases Fracture Risk

Postmenopausal Osteoporosis Bisphosphonate Drug Holiday Increases Fracture Risk

By

A retrospective study examined the risk of developing fractures in postmenopausal women with osteoporosis who discontinued bisphosphonate therapy.

Fractures in Older Men Predicted by Low DHEAS Serum Levels

Fractures in Older Men Predicted by Low DHEAS Serum Levels

By

Low serum levels of dehydroepiandrosterone, DHEA, and it's sulfate (DHEAS) in older men are markers for osteoporotic fracture risk, researchers say.

Bone Metabolism Risks Associated With Tenofovir for Hepatitis B Infection

Bone Metabolism Risks Associated With Tenofovir for Hepatitis B Infection

By

Long-term tenofovir treatment for hepatitis B infection is linked with abnormal phosphorus metabolism in a recent study.

Osteoporosis Fractures Are More Often Fatal for Men

Osteoporosis Fractures Are More Often Fatal for Men

By

Study analyzed data on 1.6 million Americans with osteoporosis aged 65 and older.

Majority of Hip Fracture Patients Do Not Take Vitamin D Consistently

Majority of Hip Fracture Patients Do Not Take Vitamin D Consistently

By

Data comes from a multicenter randomized trial involving 1,111 femoral neck fracture patients who took vitamin D after surgery.

The Handoff: Your Week in Rheumatology News - 2/24/17

The Handoff: Your Week in Rheumatology News - 2/24/17

By

Juvenile idiopathic arthritis highlights this week's edition, plus other news in the world of rheumatic disease.

Intensive Bisphosphonate Treatment in Paget's Disease Lacks Clinical Benefit

Intensive Bisphosphonate Treatment in Paget's Disease Lacks Clinical Benefit

By

Study co-investigator says most recent clinical practice guidelines provide treatment recommendation that is "not based on the evidence" but instead represents "unsubstantiated opinion."

Osteoporosis Recommendations Alter Bisphosphonate Treatment Trends

Osteoporosis Recommendations Alter Bisphosphonate Treatment Trends

By

Bisphosphonate treatment for osteoporosis among women older than 65 goes up after 2008 recommendations.

Rheumatoid Arthritis Increases Risk of Cardiovascular Disease Events After Fragility Fracture

Rheumatoid Arthritis Increases Risk of Cardiovascular Disease Events After Fragility Fracture

By

Study investigators suggest clinicians consider more aggressive preventive therapy for cardiovascular disease in patients with rheumatoid arthritis who have experienced a fragility fracture.

New Screening Method for Osteoporosis Therapy Adherence

New Screening Method for Osteoporosis Therapy Adherence

The International Osteoporosis Foundation and European Calcified Tissue Society Working Group proposed a screening strategy measuring certain bone turnover markers in patients who have initiated oral bisphosphonate therapy for postmenopausal osteoporosis as a practical way to identify low adherence.

High-Inflammation Diets May Increase Fracture Risk in Women

High-Inflammation Diets May Increase Fracture Risk in Women

By

High-inflammation diets were associated with greater bone density loss in a recent observational study.

Thyroid Cancer Survivors Face Long-Term Osteoporosis and CVD Risks

Thyroid Cancer Survivors Face Long-Term Osteoporosis and CVD Risks

By

Research shows that younger survivors are at increased risk of serious long-term health conditions resulting from thyroid cancer treatments.

Does Psoriatic Arthritis and Psoriasis Increase Risk of Fracture Development?

Does Psoriatic Arthritis and Psoriasis Increase Risk of Fracture Development?

By

A population-based cohort study compared patients with psoriatic arthritis, psoriasis, and rheumatoid arthritis with matched comparators to determine fracture risk associated with the conditions.

FDA Approves Second-Generation Osteoporosis Detection Device

FDA Approves Second-Generation Osteoporosis Detection Device

By

Finland-based Bone Index announced that the U.S. Food and Drug Administration (FDA) has approved its second-generation Bindex device to aid in diagnosing osteoporosis.

Consistent Benchmarking Improves THA Pain Outcomes

Consistent Benchmarking Improves THA Pain Outcomes

By

A standardized process for data analysis and internal benchmarking facilitated a reduction in pain following hip arthroplasty.

Alzheimer's Disease Identified as Risk Factor for Major Hip Fracture

Alzheimer's Disease Identified as Risk Factor for Major Hip Fracture

By

Cardiovascular disease, stroke, diabetes, hip and knee replacements, and both behavioral and mental disorders were also more common in the AD cohort.

Sign Up for Free e-newsletters